We sought to determine both the mRNA and protein expression of PRSS3 in invasive ductal carcinoma of the breast (IDC) tissue samples and correlate this with the patient's clinical characteristics and 5.0-year survival rate. The gene discussed is PRSS3; the disease is invasive ductal breast carcinoma.